Sleep Disorders Trial, Recruiting NCT05536076 Sponsor: VA Office of Research and Development Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05536076
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who had a spinal cord injury or disease more than 6 months ago, with any level of injury severity (classified A through D on a standard spinal injury scale), and who show signs of a sleep breathing disorder
  • People without a spinal cord injury who have been diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops and starts during sleep)

Who may not be able to join:

  • People who rely on a machine to breathe continuously (note: CPAP or similar sleep breathing devices used as standard treatment do not count as an exclusion)
  • People with severe heart failure where the heart is pumping at less than 35% of its normal capacity
  • People who have recently had a stroke, heart attack, surgery, or a hospital stay that may be affecting their sleep
  • People with a current alcohol or substance use problem, or who have not been sober for at least 90 days
  • People who feel they are too unwell to take part in the study procedures
  • People whose breathing tests show that carbon dioxide levels in their blood are too high while breathing on their own (confirm with trial site)
  • People who are not able to give their own consent to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Abdulghani Sankari, MD PhD, John D. Dingell VA Medical Center, Detroit, MI

Phone: (313) 576-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov